3989 |
Weighing the Benefit of High Intensity Statin Treatment |
Byoung Kwon Lee |
Apr. 27. 19 |
3988 |
Optimising the Approach to High Bleeding Risk (HBR) PCI Patients |
Philip M. Urban |
Apr. 27. 19 |
3987 |
DAPT Therapy in Asians: What May Be Different Between Asian and Caucasian? |
Jeehoon Kang |
Apr. 27. 19 |
3986 |
Lithotripsy for Calcific Lesion: When and How |
Lawrence A. Garcia |
Apr. 27. 19 |
3985 |
Rotational Atherectomy for Femoropopliteal Artery Disease: How to Improve Efficiency |
Jae-Hwan Lee |
Apr. 27. 19 |
3984 |
Orbital Atherectomy for the Treatment of Calcified Peripheral Arterial Disease |
Robert Bersin |
Apr. 27. 19 |
3983 |
Directional Atherectomy for Complex Femoropopliteal Artery: Where Are We, How to Do |
Ravish Sachar |
Apr. 27. 19 |
3982 |
Heavy Calcific SFA Lesion: How to Cross with Wire and Balloon |
Su Hong Kim |
Apr. 27. 19 |
3981 |
Sirolimus DCBs for Femoral-Popliteal Disease: Emerging Role and Future Perspectives |
Robert Bersin |
Apr. 27. 19 |
3980 |
Paclitaxel DCBs for Femoral-Popliteal Disease: Pitfall and Current Status |
Sang Woo Park |
Apr. 27. 19 |